Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.338 USD | +0.35% | -3.74% | -0.51% |
05-09 | Lixte Biotechnology Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-23 | Lixte Biotechnology Files Up to $50 Million Mixed Shelf | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
5.26M | - | - | - | - | - | |
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |